Last updated on March 2019

A Study to Investigate Safety and Tolerability Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease


Brief description of study

The purpose of this study is to assess the safety and tolerability of JNJ-63733657 following single ascending intravenous (IV) dose administration in healthy subjects (Part 1) and multiple ascending IV dose administrations in subjects with prodromal or mild Alzheimer's disease (AD) (Part 2).

Clinical Study Identifier: NCT03375697

Contact Investigators or Research Sites near you

Start Over

Study Contact

Clinical Pharmacology Unit
Merksem, Belgium
  Connect »

Study Contact

Centre for Human Drug Research
Leiden, Netherlands
  Connect »

Study Contact

Klinik f r Neurodegenerative Erkrankungen und Gerontopsychiatrie
Bonn, Germany
  Connect »

Study Contact

CTC North GmbH & Co. KGim Spectrum am UKE
Hamburg, Germany
  Connect »

Study Contact

Universit tsklinikum des Saarlandes
Homburg / Saar, Germany
  Connect »

Study Contact

Hosp. Clinico San Carlos
Madrid, Spain
  Connect »

Study Contact

Hosp. Univ. I Politecni La Fe
Valencia, Spain
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.